Related Experiment Video

Updated: Mar 23, 2026

Seven Steps to Stellate Cells
06:40

Seven Steps to Stellate Cells

Published on: May 10, 2011

34.9K

Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis

Mio Kitano1, P Mark Bloomston2

  • 1Division of Surgical Oncology, Department of Surgery, Wexner Medical Center, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA. kitmio@gmail.com.

Insights

MicroRNAs (miRNAs) regulate gene expression and are crucial in liver fibrosis. This review highlights miRNAs in hepatic stellate cell activation, offering potential diagnostic biomarkers and therapeutic targets for liver disease.

Area of Science:

  • Molecular Biology
  • Genetics
  • Hepatology

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
  • Hepatic fibrosis is a pathological process involving complex biological mechanisms.
  • Hepatic stellate cells (HSCs) are key players in liver fibrosis development.

Purpose of the Study:

  • To review and summarize current data on miRNAs involved in hepatic fibrosis.
  • To explore the regulatory roles of miRNAs in HSC activation, proliferation, collagen production, migration, and apoptosis.
  • To discuss the potential of miRNAs as diagnostic biomarkers and therapeutic targets for liver fibrosis.

Main Methods:

  • Literature review of scientific articles on miRNAs and hepatic fibrosis.
  • Analysis of differentially expressed miRNAs in activated HSCs.
  • Synthesis of current knowledge on miRNA functions in liver fibrosis pathogenesis.

Main Results:

  • Multiple miRNAs are differentially expressed in activated HSCs.
  • miRNAs intricately regulate HSC functions, influencing liver fibrosis progression.
  • Dysregulated miRNAs are implicated in the development and progression of hepatic fibrosis.

Conclusions:

  • miRNAs play significant roles in hepatic fibrosis development.
  • miRNAs show potential as biomarkers for liver disease diagnosis and progression monitoring.
  • Targeting dysregulated miRNAs may offer novel therapeutic strategies for treating hepatic fibrosis.